Poxel’s Novel Diabetes Med One Step Closer to World’s 1st Launch, Japan Chief Says Physicians’ Trust Holds Key

April 24, 2019
Poxel Japan President Takashi Kaneko While Poxel is sailing smoothly towards the world’s first launch in Japan for its novel diabetes treatment imeglimin, country president Takashi Kaneko says the French biopharma will work to carefully explain its trial data to...read more